Table 3.
Prevalence of sarcopenia (n %) in the middle aged study population stratified by gender and age
| Codea | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|
| Age (years) | Total | Age (years) | Total | |||||
| ≤59 | 60–69 | ≥70 | ≤59 | 60–69 | ≥70 | |||
| (n = 77) | (n = 186) | (n = 62) | (n = 325) | (n = 128) | (n = 170) | (n = 31) | (n = 329) | |
| A | 3 (3.9) | 8 (4.3) | 4 (6.5) | 15 (4.6) | 2 (1.6) | 5 (2.9) | 0 | 7 (2.1) |
| B | 3 (3.9) | 8 (4.3) | 4 (6.5) | 15 (4.6) | 4 (3.1) | 6 (3.5) | 0 | 10 (3.0) |
| C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D | 12 (15.6) | 35 (18.8) | 18 (29.0) | 65 (20.0) | 20 (15.6) | 37 (21.8) | 8 (25.8) | 65 (19.8) |
| E1 | 3 (3.9) | 17 (9.1) | 16 (25.8) | 36 (11.1) | 4 (3.1) | 8 (4.7) | 4 (12.9) | 16 (4.9) |
| E2 | 1 (1.3) | 0 | 1 (1.6) | 2 (0.6) | 0 | 0 | 1 (3.2) | 1 (0.3) |
| F1 | 16 (20.8) | 58 (31.2) | 28 (45.2) | 102 (31.4) | 0 | 0 | 1 (3.2) | 1 (0.3) |
| F2 | 0 | 0 | 1 (1.6) | 1 (0.3) | 0 | 0 | 0 | 0 |
| G | 1 (1.3) | 2 (1.1) | 5 (8.1) | 8 (2.5) | 3 (2.3) | 6 (3.5) | 0 | 9 (2.7) |
aThe letters represent codes for the applied definition. The code is fully described in Table 1